Geron Corp (GERN) option IV into FDA Oncologic Drugs Advisory Committee meeting

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/18/2026

1. SPY
2. FLNC
3. CRM
4. GNRC
5. CRWV
6. NVDA
7. LMT
8. USO
9. META
10. TLT

Go back to Geron Corp (GERN) option IV into FDA Oncologic Drugs Advisory Committee meeting

Geron Corporation (GERN) PT Raised to $5 at Goldman Sachs

March 15, 2024 3:51 AM EDT

Goldman Sachs analyst Corinne Jenkins raised the price target on Geron Corporation (NASDAQ: GERN) to $5.00 (from $4.00) while maintaining a Buy rating.

The analyst comments "

We expect GERN to trade higher tomorrow (+85-90% in after hours trading) following the FDA's Advisory... More